NCT07530744Not yet recruiting
Post-Market Registry of Transbronchial Cryo-assisted RFA During Routine Standard Bronchoscopic Tumor Stagng and Resection
Source: ClinicalTrials.gov · Last updated 15 Apr 2026
Brief summary (registry, in English)
In order to secure the diagnosis of lung cancer, the investigator will perform a bronchoscopy in order to take tissue samples. These samples will be analyzed in the pathology. This is the routine standard. The aim of the study is to treat the lesion with a device that works both with cold and radiofrequency. The device is already in use for the treatment of lesions. The device allows direct treatment of the lesion during the routine bronchoscopy. As planned, the lesion will then be surgically removed. After the surgery the lesion will be analyzed in the pathology to show the effect of the use of the device. This additional treatment is safe and will support the treatment of the lesion. There are no additional steps or assessments for the participants to undergo.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 26 Mar 2026
- Start date
- 1 May 2026
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Elisabethinen Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT07530744
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 1 May 2026 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- thoracic electronic implants
- severe uncontrolled comorbidities or infection; prior SBRT to zone
- recent investigational therapy (\<30 d)
Other illness
- atelectasis/obstructive pneumonitis/effusion/fibrosis
Lab values
- uncorrectable coagulopathy or platelets ≤50 × 10⁹/L
Other
- Pregnancy/nursing
- central tumours abutting vital structures
- investigator-determined risk.
Who the study is looking for
- Solitary nodule ≤ 2.5 cm
- Candidate for diagnostic bronchoscopy \& LN staging
- Eligible for surgical resection
- Histologically proven lung cancer
- ≥20 mm margin to pleura/vessels/bronchi
- Signed informed consent, age ≥18 y.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ordensklinikum Linz Elisabethinen Coordinator of this site? Confirm its status | Linz | Austria | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.